Glucagon-Like Peptide-1 Receptor Agonist Use and Renal Impairment: A Retrospective Analysis of an Electronic Health Records Database in the U.S. Population

INTRODUCTION: The study characterizes the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in patients with type 2 diabetes (T2D) with and without renal impairment and examines the effects of such use on the clinical outcomes of estimated glomerular filtration rate (eGFR) and glycated he...

Descripción completa

Detalles Bibliográficos
Autores principales: Boye, Kristina S., Botros, Fady T., Haupt, Axel, Woodward, Brad, Lage, Maureen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104268/
https://www.ncbi.nlm.nih.gov/pubmed/29460259
http://dx.doi.org/10.1007/s13300-018-0377-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104268/
https://www.ncbi.nlm.nih.gov/pubmed/29460259
http://dx.doi.org/10.1007/s13300-018-0377-5

Ejemplares similares